Templeton Global (GIM) 6.48 $GIM Templeton Global Income

New Post Public Reply Private Reply Replies (0) Message Board

Jun 12, 2016 at 10:05 PM

Templeton Global (GIM) 6.48 $GIM

Templeton Global Income Fund ("GIM"

Announces Dividend
Marketwired - Wed Jun 01, 8:30AM CDT
FORT LAUDERDALE, FL--(Marketwired - Jun 1, 2016) - Templeton Global Income Fund (NYSE: GIM) today announced its regular monthly dividend from net investment income of $0.025 per share, payable on June 30, 2016, to shareholders of record on June 16, 2016 (Ex-Dividend Date: June 14, 2016).
GIM: 6.48 (-0.07), BEN: 33.79 (-0.63)

Templeton Releases Closed-End Fund's Portfolio Allocation Update
Marketwired - Fri May 13, 1:47PM CDT
FORT LAUDERDALE, FL--(Marketwired - May 13, 2016) - The Templeton closed-end Fund referenced below, which trades on the New York Stock Exchange, today released a portfolio allocation update containing the following information as of April 30, 2016:
GIM: 6.48 (-0.07), BEN: 33.79 (-0.63)

Shares of GIM Down 26.5% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri Apr 22, 1:29PM CDT
SmarTrend identified a Downtrend for Templeton Global Income Fund (NYSE:GIM) on May 18th, 2012 at $8.89. In approximately 48 months, Templeton Global Income Fund has returned 26.50% as of today's recent price of $6.53.
GIM: 6.48 (-0.07)

Templeton Releases Closed-End Funds' Portfolio Allocation Updates
Marketwired - Mon Apr 18, 10:41AM CDT
The Templeton closed-end Funds referenced below, which trade on the New York Stock Exchange, today released portfolio allocation updates containing the following information as of March 31, 2016:
GIM: 6.48 (-0.07), TDF: 17.04 (-0.27), BEN: 33.79 (-0.63)

Templeton Global Income Fund Down 26.8% Since SmarTrend Downtrend Call (GIM)
Comtex SmarTrend(R) - Fri Apr 15, 12:49AM CDT
SmarTrend identified a Downtrend for Templeton Global Income Fund (NYSE:GIM) on May 18th, 2012 at $8.89. In approximately 48 months, Templeton Global Income Fund has returned 26.77% as of today's recent price of $6.51.
GIM: 6.48 (-0.07)

Downtrend Call Working As Templeton Global Income Fund Stock Falls 27.0% (GIM)
Comtex SmarTrend(R) - Thu Mar 31, 12:50AM CDT
SmarTrend identified a Downtrend for Templeton Global Income Fund (NYSE:GIM) on May 18th, 2012 at $8.89. In approximately 47 months, Templeton Global Income Fund has returned 27.00% as of today's recent price of $6.49.
GIM: 6.48 (-0.07)

29.8% Return Seen to Date on SmarTrend Templeton Global Income Fund Call (GIM)
Comtex SmarTrend(R) - Fri Mar 04, 4:46PM CST
SmarTrend identified a Downtrend for Templeton Global Income Fund (NYSE:GIM) on May 18th, 2012 at $8.89. In approximately 46 months, Templeton Global Income Fund has returned 29.81% as of today's recent price of $6.24.
GIM: 6.48 (-0.07)

Templeton Global Income Fund Has Returned 29.2% Since SmarTrend Recommendation (GIM)
Comtex SmarTrend(R) - Wed Feb 03, 6:21PM CST
SmarTrend identified a Downtrend for Templeton Global Income Fund (NYSE:GIM) on May 18th, 2012 at $8.89. In approximately 45 months, Templeton Global Income Fund has returned 29.25% as of today's recent price of $6.29.
GIM: 6.48 (-0.07)

Templeton Global Income Fund Shares Down 31.8% Since SmarTrend's Sell Call (GIM)
Comtex SmarTrend(R) - Wed Jan 27, 2:09PM CST
SmarTrend identified a Downtrend for Templeton Global Income Fund (NYSE:GIM) on May 18th, 2012 at $8.89. In approximately 45 months, Templeton Global Income Fund has returned 31.83% as of today's recent price of $6.06.
GIM: 6.48 (-0.07)

33.7% Return Seen to Date on SmarTrend Templeton Global Income Fund Call (GIM)
Comtex SmarTrend(R) - Wed Jan 20, 10:53AM CST
SmarTrend identified a Downtrend for Templeton Global Income Fund (NYSE:GIM) on May 18th, 2012 at $8.89. In approximately 45 months, Templeton Global Income Fund has returned 33.75% as of today's recent price of $5.89.
GIM: 6.48 (-0.07)

Templeton Global Income Fund Has Returned 33.7% Since SmarTrend Recommendation (GIM)
Comtex SmarTrend(R) - Wed Jan 20, 10:36AM CST
SmarTrend identified a Downtrend for Templeton Global Income Fund (NYSE:GIM) on May 18th, 2012 at $8.89. In approximately 45 months, Templeton Global Income Fund has returned 33.75% as of today's recent price of $5.89.
GIM: 6.48 (-0.07)

Downtrend Call Working As Templeton Global Income Fund Stock Falls 30.5% (GIM)
Comtex SmarTrend(R) - Wed Jan 13, 9:43AM CST
SmarTrend identified a Downtrend for Templeton Global Income Fund (NYSE:GIM) on May 18th, 2012 at $8.89. In approximately 45 months, Templeton Global Income Fund has returned 30.48% as of today's recent price of $6.18.
GIM: 6.48 (-0.07)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Electra Defense's $4.7M Contract Fuels USAF Innovation

Electra's Latest Win: A $4.7M USAF Experiment Forget your typical aviation story, folks. Electra Defense just scored a whopping $4.7 million contract from the U.S. Air Force Research Laboratory. The goal? To push the boundaries of hybrid-electric aircraft tech, specifically their Ultra-Short Takeoff and Landing (Ultra-STOL) capabilities. This isn't about pie-in-the-sky...

Trimble Unveils Bold AI Tools in Construction Push

Trimble Connect's Bold Move in AI In the relentless world of construction, where risk is as common as a hard hat, Trimble's rolling out some heavy-duty AI capabilities. Today, at the annual Trimble Dimensions bash in Las Vegas, the bigwigs at Trimble (NASDAQ:TRMB) flashed their latest trick: Trimble Connect's AI arsenal. It's not just a software upgrade; it's practically...

Solstice Advances Foam Agent with Eco-Friendly Twist

A New Phase in Foam Blowing Agents You don’t come across a true leap in materials technology every day, and that’s exactly what's unfolding with Solstice Advanced Materials' latest venture. They’re not just talking the talk; they've hit a milestone in developing a next-gen foam blowing agent. This isn't just another tweak in a spreadsheet—it's a potential pivot in...

NSAP's First Board Aims to Revolutionize Autism Care

Out in Silicon Valley, where innovation isn’t just a buzzword, the National Society of Autism Professionals (NSAP) is stirring the pot with some serious leadership moves. Just this month, they cobbled together their inaugural board of directors—a gathering of eight experts from every corner of the autism field you can think of. They’re not playing small ball, no...

Texas Author's Memoir Journeys Through Trauma and Growth

Finding Clarity Amid Chaos When life throws the unexpected, some folks crumble, but others, like Joyce L. Skala, sift through the rubble for clarity. Her debut memoir, "There's No Such Thing as Bad," weaves through personal chaos—embracing trauma and loss like a late-night poker game where the house always wins. Born from the charred memories of her family's home...

Outer Spaces Unveils OS1 at Major Energy Expo

Introduction to the Future of Solar Living Just when you thought you'd seen it all, along comes Outer Spaces with their OS1—a solar pavilion and battery deck that looks at residential energy with fresh eyes. Debuting at the RE+ 2026 in Las Vegas, this isn't just another gizmo. This is about bringing solar power to your backyard without making your roof look like it...

Inner City Visions Celebrates Two Decades of Impact

Alfred Lomas' Transformation Fuels Lasting Change Once upon a time, Alfred Lomas was known as a brawler in the rough patches of South L.A., running with gangs and entangled in violence. But the story flipped, and instead of leaning into chaos, Lomas leaned into hope. That personal turnaround isn't just a headline—it's the crux behind Inner City Visions (ICV), the...

LASEROPTEK Embraces CPT Clarity: Impacts on Dermatology

CPT Changes: A New Era for Dermatology? Get this: the American Medical Association's revisions to the CPT codes could be just the spark LASEROPTEK's been waiting for. Landing on the desk is the 2027 Current Procedural Terminology (CPT) code set which clarifies how docs report targeted UVB laser treatments. We're talking about codes 96920–96922, now clear as crystal,...

Foundayo Aims to Revolutionize Sleep Apnea Treatment

Revolution in Sleep Health The paper has officially announced a promising shift in sleep apnea treatment. Eli Lilly's Foundayo, revealed through a Phase 3 clinical program, is looking to tackle obstructive sleep apnea (OSA) with unprecedented potential. Forget the traditional methods—this small molecule GLP-1 receptor agonist could be a game changer for folks plagued by...

Chipotle's BOGO Promo Returns: Tattoos Boost Sales

Chipotle's BOGO Charade: A Tattooed Affair You've got to hand it to Chipotle—they know how to turn heads and wallets with their quirky promotions. The upcoming 'Tatted Like a Chipotle Bag' offer is a prime example of how they ride the cultural zeitgeist as they gear up for another record-breaking day on Friday, November 13. And seriously, with tattoos in play, they're...